Consistent with these results, Zang and collaborators have shown an imbalance between NE and AAT serum concentrations in individuals with biopsy-diagnosed NAFLD when compared with healthy individuals. The gene discussed is SERPINA1; the disease is metabolic dysfunction-associated steatotic liver disease.